PATENT CLAIM ANALYSIS

Application Number: 16031819
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["435", "440000"]

Abstract:
Compositions and methods for using nucleosome interacting protein domains to increase accessibility of programmable DNA modification proteins to target chromosomal sequences, thereby increasing efficiency of targeted genome/epigenetic modification in eukaryotic cells.

Claim (Index 7):
The fusion protein of  claim 1 , wherein the at least one nucleosome interacting protein domain is linked to the CRISPR protein directly via a chemical bond, indirectly via a linker, or a combination thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.1
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15437148', '14105017', '15179912', '15935334', '15369533']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5978317252572178
- 35 USC 102 Novelty (BERT): 0.5365702633672309
- Combined Prediction Score: 0.5917055790682192
- Mean Citation Score: 363.518024
- Max Citation Score: 385.41925
- Similarity Product: 265.0104692145586

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test